Citigroup’s Bolt Biotherapeutics BOLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-115
Closed -$2.58K 4817
2023
Q4
$2.58K Buy
+115
New +$2.58K ﹤0.01% 4608
2023
Q1
Sell
-2
Closed -$56 4749
2022
Q4
$56 Sell
2
-23
-92% -$644 ﹤0.01% 4852
2022
Q3
$1K Sell
25
-18
-42% -$720 ﹤0.01% 4776
2022
Q2
$2K Sell
43
-368
-90% -$17.1K ﹤0.01% 5054
2022
Q1
$22K Buy
411
+49
+14% +$2.62K ﹤0.01% 4359
2021
Q4
$35K Buy
362
+220
+155% +$21.3K ﹤0.01% 4454
2021
Q3
$36K Buy
142
+103
+264% +$26.1K ﹤0.01% 4166
2021
Q2
$12K Sell
39
-3
-7% -$923 ﹤0.01% 4884
2021
Q1
$28K Buy
+42
New +$28K ﹤0.01% 4382